At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2b, Double-blind, Randomised, 5-arm, Vehicle-controlled, Dose-ranging Trial to Evaluate the Efficacy and Safety of Twice Daily Topical Application of Delgocitinib Cream 1, 3, 8, and 20 mg/g for 16 Weeks in Adult Subjects With Mild to Severe Chronic Hand Eczema
In Brief
A Phase 2 clinical trial evaluating Delgocitinib cream and Delgocitinib cream vehicle for Chronic Hand Eczema. Completed, enrolled 258 participants across 28 sites in 3 countries.
Detailed Summary
The purpose of this research trial was to test different strengths of a new trial medication, delgocitinib cream 1, 3, 8, and 20 mg/g, and to investigate how treatment with delgocitinib cream affects chronic hand eczema. This was judged by a range of assessments that rate the severity and extent of chronic hand eczema and its symptoms, as well as general health status and quality of life.
Study Details
Timeline
Interventions
Cream for topical application.
The cream vehicle is similar to the delgocitinib cream except that it does not contain any active ingredient.